Balyasny Asset Management L.P. Has $5.87 Million Stake in Encompass Health Co. (NYSE:EHC)

Balyasny Asset Management L.P. lowered its stake in shares of Encompass Health Co. (NYSE:EHC) by 57.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 63,607 shares of the company’s stock after selling 85,402 shares during the quarter. Balyasny Asset Management L.P. owned about 0.06% of Encompass Health worth $5,874,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Encompass Health by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after purchasing an additional 138,196 shares during the last quarter. Invesco Ltd. lifted its position in shares of Encompass Health by 3.3% during the 4th quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock worth $511,273,000 after buying an additional 176,135 shares during the last quarter. Alliancebernstein L.P. grew its position in Encompass Health by 6.0% in the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock valued at $191,799,000 after acquiring an additional 117,617 shares during the last quarter. FMR LLC raised its stake in Encompass Health by 0.8% during the fourth quarter. FMR LLC now owns 1,973,846 shares of the company’s stock worth $182,285,000 after acquiring an additional 15,831 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Encompass Health by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after acquiring an additional 6,164 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Up 0.5 %

Encompass Health stock opened at $116.45 on Friday. The firm has a market cap of $11.74 billion, a price-to-earnings ratio of 26.11, a PEG ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a 52-week low of $82.74 and a 52-week high of $118.27. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The firm has a 50 day moving average price of $103.44 and a two-hundred day moving average price of $99.96.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the previous year, the business earned $1.12 earnings per share. Encompass Health’s revenue for the quarter was up 10.6% on a year-over-year basis. Equities analysts predict that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.58%. Encompass Health’s dividend payout ratio is currently 14.05%.

Insider Buying and Selling at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of the firm’s stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the completion of the sale, the executive vice president now owns 79,710 shares of the company’s stock, valued at $9,149,910.90. The trade was a 11.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 19,321 shares of company stock valued at $2,142,452. 2.00% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on EHC shares. KeyCorp upped their price objective on shares of Encompass Health from $120.00 to $122.00 and gave the stock an “overweight” rating in a research report on Friday, April 25th. Barclays raised their price objective on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a report on Friday, April 25th. Truist Financial reaffirmed a “buy” rating and issued a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a report on Monday, April 28th. William Blair reiterated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Finally, UBS Group boosted their target price on shares of Encompass Health from $117.00 to $130.00 and gave the stock a “buy” rating in a report on Monday, April 28th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $120.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.